Min‐Yen Lo

Validation of the prognostic significance of the 2022 European <scp>LeukemiaNet</scp> risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia

Min‐Yen Lo, Chien‐Chin Lin, Feng‐Ming Tien et al. · American Journal of Hematology · 2023 · 40 citations · Full text

Medicine, Oncology, Chemotherapy +9

Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML

Kuo-Jui Sun, Min‐Yen Lo, Feng‐Ming Tien et al. · Blood Cancer Journal · 2023 · 38 citations · Full text

Medicine, Genetics, Oncology +8

Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience

Yuwen Wang, Hsin‐An Hou, Feng‐Ming Tien et al. · Annals of Hematology · 2021 · 26 citations

Medicine, Oncology, Pharmacotherapy +12

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

Wan‐Hsuan Lee, Ming-Tao Tsai, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2023 · 26 citations · Full text

Medicine, Hematology, Molecular Medicine +17

Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms

Wan‐Hsuan Lee, Chien‐Chin Lin, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2024 · 26 citations · Full text

Medicine, Hematology, Pathology +17